Biomarkers are biological markers which measure the biological states. It is used for indicating the normal biological and pathogenic process to a therapeutic intervention. These biomarkers can also be used in combination to access disease state of an individual. Scientists are exploring more about the structural and functional differences of the neurological diseases. Moreover, there has been an increase in biobanks which have help address unmet needs in oncology, neuroscience, and cardiovascular disease.
This report elaborates the market size, market characteristics, and market growth of the Neurological Biomarkers industry, and breaks down according to the type, application, and consumption area of Neurological Biomarkers. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Neurological Biomarkers in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Neurological Biomarkers market covered in Chapter 13:
Aepodia
Acumen Pharmaceuticals
AbaStar MDx
Proteome Sciences
Abiant
ImmunArray
Athena Diagnostics
Cisbio Bioassays
Myriad RBM
QIAGEN
Thermo Fisher Scientific
Quanterix

In Chapter 6, on the basis of types, the Neurological Biomarkers market from 2015 to 2025 is primarily split into:
Alzheimer's disease (AD)
Multiple sclerosis (MS)
Parkinson's disease (PD)
Autism spectrum disorder (ASD)

In Chapter 7, on the basis of applications, the Neurological Biomarkers market from 2015 to 2025 covers:
Hospitals
Clinics
Diagnostic and research laboratories

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025